Canadian Organization for Rare Disorders (CORD)

5th Rare Disease Day Conference
February 27-28, 2013
Toronto, ON
Panel title: “What if Patients Truly did Drive Research?”
Title of presentation: “Patients as Researchers in Personalized Medicine”
Panelist:  Ms. Katherine Bonter

Molecular Dx for Cancer Drug Development

June  18-20, 2013
Boston, MA
Presentation: “Current Trends and Challenges facing Innovation and Commercialization of Personalized Medicine”
Presentor: Ms. Katherine Bonter


4th Annual Market Access Canada

Nov  21-22, 2012
Toronto, ON
Presentation: “Hear the Latest on Personalized Medicine in Canada”
Presentor: Ms. Katherine Bonter


Mars Future of Medicine 2012

Nov 15, 2012
Toronto, ON
Presentation: “Commercialization in Personalised Medicine, a Canadian Perspective”
Presentor: Ms. Katherine Bonter

World CDx

Nov 13-15, 2012
Boston, MA
Presentation: “Strategies for successful public-private partnerships in PM”
Presentor: Ms. Katherine Bonter

Symposium sur les Soins de Santé Personnalisés en Cancer

May 23rd 2012
Montreal, Quebec
Presentation: “Vers les soins de santé personnalisés”
Presentor: Dr. Clarissa Desjardins



11th Annual Money Research Conference

May 16-17, 2012
Ottawa, Ontario
Panel discussion: “Implications for Innovation Support Organizations”
Panelist: Dr. Clarissa Desjardins



Centre for Clinical Epidemiology SMBD Jewish General Hospital

February 21, 2012
Montreal, Qc
Presentation: “Pharmacogenomics of  Warfarin: Beyond Dose Prediction”
Presenting:  Dr. Marie-Pierre Dubé, Director, Montreal University, Beaulieu-Saucier Pharmacogenomics Centre, MHI


Canadian Undergraduate Conference on Healthcare (CUCOH 2011)

November 18 to 20, 2011
Kingston, Ontario
Discussion panel: “The sustainability of Canada’s Healthcare”
Presentation: “Personalized Medicine and its Impact on the Canadian Healthcare System”
Presenting: Katherine Bonter

Canadian Cancer Research Conference (CCRC)

November 27-30, 2011
Toronto, ON
Poster entitled: “Personalized Medicine, Implementation in Canada”
Presenting: Anick Dubois

Perspectives philosophiques sur la médecine personnalisée

October 21-23, 2011
Paris, France
“Les enjeux de la médecine personnalisée dans la pratique clinique”
Presenting: Dr. Anick Dubois
Atelier pluridisciplinaire du projet ANR Nano2E

McGill Research Group on Health and Law

October 5th, 2011
Montreal, Qc
Interdisciplinary Panel Discussion: “The Risk and Promises of Pharmacogenetics and Personalized Medicine”
Participating: Dr. Michael Phillips, Director, Molecular Diagnostic Laboratory & Technology Development, MHI


Cancer Care Ontario – Mapping a way Through the Double Helix

December 8th, 2010
Toronto, Ontario
“Landscape of personalized medicine in Canada”
Presenting: Katherine Bonter

DIA’s 8th Annual Canadian Meeting

November 4-5, 2010
Ottawa, Ontario
“The Personalized Medicine Landscape”
Presenting: Dr. Clarissa Desjardins

DIA’s 9th Annual Canadian Meeting

November 1 to 2, 2011
Ottawa, Ontario
Track : “Personalized Medicine: A Revolution in Healthcare” 
Presentation entitled: “Personalised Medicine Value in Canada”
Presenting: Katherine Bonter

Canadian Arthritis Network Annual Scientific Conference

October 27 to 28, 2011
Quebec, Qc
“Landscape of Personalized Medicine in Canada”
Presenting: Katherine Bonter
Forum: “Personalized Medicine: What does it mean to you?”
Participating: Anick Dubois

Association of Family Health Teams of Ontario (AFHTO)

October 25 to 26, 2011
Toronto, Ontario
Poster entitled: “Genetics and Personalized Medicine in Primary Care”
Presenting: Katherine Bonter

10th Annual Market Access Summit

November 15 to 16, 2011
Toronto, Ontario
“Commercial Impacts of Personalized Medicine in Canada”
Speaker : Clarissa Desjardins

3rd Annual Critical Markers of Disease (CMOD) Meeting

May 24 to 25, 2011
Ottawa, Ontario
“The Personalized Medicine Landscape”
Speaker: Dr. Clarissa Desjardins

The Canadian Association for Population Therapeutics Annual Meeting

April 17-19, 2011
Ottawa, ON
Presentation: “Methods in Pharmacogenomics”
Presenting: Dr. Marie-Pierre Dubé, Director, University of Montreal, Beaulieu Saucier Pharmacogenomics Centre, MHI